At a glance
ClinicalIndex Comparison RecordN/ACompleted· 34 enrolled
Drug / intervention
Diosmiplexdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vasculera in Participants With Lipedema an Exploratory Controlled Case Study
In Brief
A clinical study evaluating Diosmiplex for Lipedema. Completed, enrolled 34 participants across 1 site.
Detailed Summary
This study is designed to gain preliminary information via a uniform protocol regarding the clinical effects of Vasculera in participants with lipedema and the possible role of the glycocalyx as a physiological target for Vasculera activity. It is anticipated that the results of this case study will inform the development of a formal randomized, double-blind, placebo controlled trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLipedema
CountriesUnited States
CollaboratorsNortheastern University
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartMay 2019
Primary CompletionSep 2019
First PostedNov 2022
TodayJul 2026
First PostedNov 15, 2022
Enrollment StartMay 26, 2019
Primary CompletionSep 23, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.6 years ago
Interventions
Diosmiplexdietary
diosmin glycoside in combination with alkaline granules known as alka4-complex